首页> 中文期刊> 《国际医药卫生导报》 >定期程控和随访对心脏起搏患者生活质量和起搏器寿命的影响

定期程控和随访对心脏起搏患者生活质量和起搏器寿命的影响

摘要

Objective To investigate the effect of regular program control and follow-up on the life quality and pacemaker's life span of patients with cardiac pacing.Methods 196 patients undergoing pacemaker implantation at our hospital from January,2005 to January,2015 were followed up regularly.All the patients were followed up for within 1 weeks after surgery once every 3 months.Among the 196 patients,176 patients (93%) having received regular program control and follow-up 6 months to 9 years were set as an observation group and the rest 20 cases a control group.The complications,health status,quality of life and pacemaker's life span were compared between these two groups.Results The incidence of complications was significantly lower in the observation group than in the control group (9.7% vs.35.0%,P<0.01).The scores of 8 health concepts in SF-36 scale were significantly higher in the observation group than in the control group (P<0.05 or P<0.01).The quality of life of patients was significantly higher in the observation group than in the control group (96.6% vs.65.0%,P<0.01).The pacemaker's life span was significantly longer in the observation group than in the control group [(8.87±2.33) years vs.(7.57±2.12),P<0.01].Conclusions Regular program control and follow-up for patients with pacemaker implantation can find out their complications in time and treat them in time.Regular program control and follow-up can significantly improve the patient's health status and satisfaction of quality of life and significantly extend the pacemaker's life span.Therefore,it is essential to control and follow up pacemaker-implanted patients.%目的 探讨定期程控和随访对心脏起搏患者生活质量和起搏器寿命的影响.方法 对2005年1月至2015年1月于本院植入起搏器的196例患者进行定期随访及程控.所有患者手术后1周内开始每3个月1次的程控随访.196例患者中,176例患者(93%)得到定期程控和随访,作为观察组,程控随访时间最长9年,最短6个月;20例未得到定期程控和随访,作为对照组.比较两组并发症发生情况、健康状况、生活质量满意情况以及起搏器寿命等.结果 观察组并发症发生率(9.7%)明显低于对照组(35.0%)(P<0.01).观察组在SF-36量表中8个健康概念的得分均明显高于对照组(P<0.05或P< 0.01).观察组生活质量满意率(96.6%)明显高于对照组(65.0%)(P<0.01).观察组患者的起搏器寿命[(8.87±2.33)年]明显高于对照组[(7.57±2.12)年](P<0.01).结论 对起搏器植入患者定期程控和随访可及时发现患者的并发症,使患者得到及时治疗.定期程控和随访能够显著提高患者的健康状况以及生活质量满意度,此外还能够明显延长起搏器的寿命.因此定期程控和随访对起搏器植入患者至关重要,应予以高度重视.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号